Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation.

ABSTRACT:

Purpose

Cognitive impairment is common and consequential in patients with cancer who undergo allogeneic hematopoietic stem cell transplantation (HSCT). However, there is no standard of care for evaluating cognition in patients prior to or after receiving HSCT, and it is not known which patients are at highest risk for cognitive impairment. The objectives of this study were to describe cognitive function in patients prior to allogeneic HSCT and identify demographic, disease-related, and psychosocial factors associated with cognitive function.

Methods

Prior to HSCT, participants completed the Montreal Cognitive Assessment (MoCA). We assessed bivariable associations between continuous MoCA scores and demographic, disease-related, and psychosocial variables using linear regressi

SUBMITTER: Nakamura ZM 

PROVIDER: S-EPMC7897215 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature